Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Footnotes
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Corrigendum Free access | 10.1172/JCI87364

Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects

John S. Millar, Gissette Reyes-Soffer, Patricia Jumes, Richard L. Dunbar, Emil M. deGoma, Amanda L. Baer, Wahida Karmally, Daniel S. Donovan, Hashmi Rafeek, Laura Pollan, Junichiro Tohyama, Amy O. Johnson-Levonas, John A. Wagner, Stephen Holleran, Joseph Obunike, Yang Liu, Rajasekhar Ramakrishnan, Michael E. Lassman, David E. Gutstein, Henry N. Ginsberg, and Daniel J. Rader

Find articles by Millar, J. in: JCI | PubMed | Google Scholar

Find articles by Reyes-Soffer, G. in: JCI | PubMed | Google Scholar

Find articles by Jumes, P. in: JCI | PubMed | Google Scholar

Find articles by Dunbar, R. in: JCI | PubMed | Google Scholar

Find articles by deGoma, E. in: JCI | PubMed | Google Scholar

Find articles by Baer, A. in: JCI | PubMed | Google Scholar

Find articles by Karmally, W. in: JCI | PubMed | Google Scholar

Find articles by Donovan, D. in: JCI | PubMed | Google Scholar

Find articles by Rafeek, H. in: JCI | PubMed | Google Scholar

Find articles by Pollan, L. in: JCI | PubMed | Google Scholar

Find articles by Tohyama, J. in: JCI | PubMed | Google Scholar

Find articles by Johnson-Levonas, A. in: JCI | PubMed | Google Scholar

Find articles by Wagner, J. in: JCI | PubMed | Google Scholar

Find articles by Holleran, S. in: JCI | PubMed | Google Scholar

Find articles by Obunike, J. in: JCI | PubMed | Google Scholar

Find articles by Liu, Y. in: JCI | PubMed | Google Scholar

Find articles by Ramakrishnan, R. in: JCI | PubMed | Google Scholar

Find articles by Lassman, M. in: JCI | PubMed | Google Scholar

Find articles by Gutstein, D. in: JCI | PubMed | Google Scholar

Find articles by Ginsberg, H. in: JCI | PubMed | Google Scholar

Find articles by Rader, D. in: JCI | PubMed | Google Scholar

Published April 1, 2016 - More info

Published in Volume 126, Issue 4 on April 1, 2016
J Clin Invest. 2016;126(4):1603–1604. https://doi.org/10.1172/JCI87364.
Copyright © 2016, American Society for Clinical Investigation
Published April 1, 2016 - Version history
View PDF

Related article:

Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects
John S. Millar, … , Henry N. Ginsberg, Daniel J. Rader
John S. Millar, … , Henry N. Ginsberg, Daniel J. Rader
Corrigendum

Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects

  • Text
  • PDF
Abstract

Authors

John S. Millar, Gissette Reyes-Soffer, Patricia Jumes, Richard L. Dunbar, Emil M. deGoma, Amanda L. Baer, Wahida Karmally, Daniel S. Donovan, Hashmi Rafeek, Laura Pollan, Junichiro Tohyama, Amy O. Johnson-Levonas, John A. Wagner, Stephen Holleran, Joseph Obunike, Yang Liu, Rajasekhar Ramakrishnan, Michael E. Lassman, David E. Gutstein, Henry N. Ginsberg, Daniel J. Rader

×

Original citation: J Clin Invest. 2015;125(6):2510–2522. doi:10.1172/JCI80025.

Citation for this corrigendum: J Clin Invest. 2016;126(4):1603–1604. doi:10.1172/JCI87364.

In Table 4, the units for ApoC-III conc. were incorrect. The correct table is below.

Table 4

Factors known to be associated with ApoB clearance: mean baseline values, percentage change from baseline, and between-period differences for subjects in the total population and by panel

The authors regret the error.

Footnotes

See the related article beginning on page 2510.

Version history
  • Version 1 (April 1, 2016): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Footnotes
  • Version history
Advertisement
Advertisement

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts